The World Health Organization identifies antibiotic resistance as a global challenge so serious that it threatens the fundamental achievement of modern medicine. Looking at human use and the use of antibiotics in meat production – what can we do to stimulate research into new antibiotics and to regulate the current use of antibiotics? How does collective responsibility and its ethical implications play its part?
Join in on Twitter with #oxmartintalks
About the speakers
Steven J. Hoffman is the Director of the Global Strategy Lab; Professor of Global Health, Law, and Political Science at York University; and the Scientific Director of the Canadian Institutes of Health Research's Institute of Population & Public Health. He holds courtesy appointments as a Professor of Clinical Epidemiology & Biostatistics (Part-Time) at McMaster University and Adjunct Professor of Global Health & Population at Harvard University. He is an international lawyer licensed in both Ontario and New York who specialises in global health law, global governance and institutional design. His research integrates analytical, empirical and big data approaches to craft global regulatory strategies that better address transnational health threats, social inequalities and human rights challenges. Past studies have focused on access to medicines, antimicrobial resistance, health misinformation, pandemics and tobacco control. Currently he is co-principal investigator of a large $4.6 million CAD research consortium on “Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities (i4C)” with Trygve Ottersen at the Norwegian Institute of Public Health. He is a regular columnist with Vox and writes the Burden of Proof column with journalist Julia Belluz. He is on the Executive Advisory Committee and was a Founding Editor of Wiley's new premier open-access journal Global Challenges.
Steven previously worked as a Project Manager for the World Health Organization in Geneva, Switzerland, and as a Fellow in the Executive Office of United Nations Secretary-General Ban Ki-moon in New York City, where he offered strategic and technical input on a range of global health issues. He also previously worked for a Toronto law firm specialising in cross-border intellectual property litigation, health product regulation, and government relations, as well as Incentives for Global Health – a Yale University-based NGO devoted to improving global access to medicines – where he was responsible for international advocacy and strategic planning. Steven recently advised the World Health Organization on development of a global strategy for health systems research and was lead author on the background paper that provided the strategy's conceptual underpinnings. For three years he convened an academic advisory committee on science reporting for Canada's only national weekly current affairs magazine. He was previously an Associate Professor of Law with the University of Ottawa's Centre for Health Law, Policy & Ethics.
Professor Julian Savulescu is Co-Director of the Oxford Martin Programme on Collective Responsibility for Infectious Disease; Co-Director of the Oxford Martin Programme on Geoengineering; Uehiro Chair in Practical Ethics; and Director of the Oxford Uehiro Centre for Practical Ethics at the University of Oxford.
His areas of research include: the ethics of genetics, especially predictive genetic testing, pre-implantation genetic diagnosis, prenatal testing, behavioural genetics, genetic enhancement, gene therapy. Research ethics, especially ethics of embryo research, including embryonic stem cell research. New forms of reproduction, including cloning and assisted reproduction. Medical ethics, including end of life decision-making, resource allocation, consent, confidentiality, decision-making involving incompetent people, and other areas. Sports ethics. The analytic philosophical basis of practical ethics. Julian is a founder member of the Hinxton Group.